FP02 Beta Training for Drug-Resistant Depression—A New Protocol That Usually Reduces Depression and Keeps It Reduced
AbstractOne hundred eighty-three patients with drug resistant depression were trained with 6 sessions of neurofeedback to reduce 2–7 Hz and increase 15–18 Hz at FP02 (the right fronto-polar orbital location). Remission or significant improvement (50%) occurred in 84% of subjects, as judged by the Rush Quick Self-Rated Depression Inventory. An additional 9% of patients experienced partial improvement. Improvement was maintained for 1 year or longer in all but 3 patients (1% of the entire group). These results indicate good efficacy in reducing drug-resistant depression and maintenance of the reductions in the majority of patients.
© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article. From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).